Navigation Links
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Date:5/22/2013

to noon (CDT) in S 405Presented:Saturday, June 1, noon to 1 p.m. (CDT) in S 406 

About QuizartinibQuizartinib (AC220) is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently under evaluation in a Phase 2b clinical trial as monotherapy treatment for adult patients with relapsed or refractory AML, and in two Phase 1 studies in a combination treatment regimen with chemotherapy, and as a maintenance therapy following transplant, respectively.

About Ambit BiosciencesAmbit is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. Ambit's lead drug candidate, quizartinib (AC220), is a once-daily, orally-administered potent and selective, inhibitor of FMS-like tyrosine kinase-3 (FLT3) and is currently under clinical development in patients with relapsed/refractory acute myeloid leukemia (AML) and in newly diagnosed AML patients in combination with chemotherapy as well as maintenance following a hematopoietic stem cell transplantation (HSCT). In addition to quizartinib, Ambit's clinical pipeline includes AC410, an oral JAK2 inhibitor, and CEP-32496, a BRAF inhibitor licensed to Teva Pharmaceutical Industries Ltd. Ambit's preclinical portfolio includes a proprietary CSF1R inhibitor program.

Forward-Looking StatementsStatements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Ambit's expectations regarding future therapeutic and commercial potential of Ambit's lead drug candidate and pipeline, business plans, technologies and intellectual property. Because such statements are subject to risks and uncertainties, actual results may diffe
'/>"/>

SOURCE Ambit Biosciences Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
2. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
3. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
4. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
5. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
6. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
7. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
10. Neurocrine Biosciences Reports First Quarter 2012 Results
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 Bayer HealthCare ... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) on ISIS-FXI ... for the prevention of thrombosis. Under the agreement Bayer ... areas of high unmet medical need. As part of ... therapeutic profile of ISIS-FXI Rx in an appropriate ...
(Date:5/4/2015)... LOS ANGELES , May 4, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... phase 1b aldoxorubicin combination studies pairing aldoxorubicin with ... doses of gemcitabine or ifosfamide with escalating doses ... tolerated, and even at the lowest dose level ...
(Date:5/4/2015)... , May 4, 2015 Dyadic ... company whose patented and proprietary technologies are used ... proteins for the bioenergy, bio-based chemical, biopharmaceutical and ... report its financial results for quarter ending March ... 14, 2015 and will host a conference call ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3
... FALL RIVER , Mass., Sept. 28 ... new professionals to support operations in the Memphis, TN, facility. ... to serve as Medical Director.  His role will be to ... tissue bank.  Wade A. Hanes, a former Master Chief in ...
... Sept. 28 Reportlinker.com announces that a new ... Global Magnetic Resonance Imaging ... http://www.reportlinker.com/p0304768/Global-Magnetic-Resonance-Imaging-MRI-Systems-Market-2010---2015.html ... Market (2008 – 2015) The global ...
Cached Medicine Technology:Millstone Medical Outsourcing Makes Strategic Hires in Memphis 2Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 2Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 3Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 4Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 5Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 6Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 7Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 8Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 9Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 10Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 11
(Date:5/4/2015)... The U.S. healthcare worker shortage crisis is expected ... senior citizens (1) and 27 million Obamacare-insured Americans (2) ... Additionally, as older healthcare employees retire, there will be ... Census Bureau, the number of American workers 65 and ... those 25 to 54 will likely increase 2%. (3) ...
(Date:5/4/2015)... WA (PRWEB) May 04, 2015 EyeCRO ... a collaboration to facilitate development of NM108, a first-in-class ... that lead to blindness, including Diabetic Retinopathy. The ... platform developed by EyeCRO, which can deliver drugs to ... topical eyedrop. , Under the terms of the ...
(Date:5/4/2015)... New findings released today from a ... show that people diagnosed with a brain tumor needed ... clinical trials, at the time of diagnosis, and had ... about their course of treatment. The release of these ... brain tumor volunteer network, the ABTA CommYOUnity™, dedicated to ...
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Sheltering ... Learning Center from Hale House. The Mother Hale Learning ... high-quality, affordable Early Childhood Education. Sheltering Arms will begin ... continue to be served by the center. , Opened ... children ages six weeks to five years, many of ...
(Date:5/4/2015)... May 04, 2015 Elisabeth Rosenthal’s ... a stir and showed the healthcare fraternity as ... healthcare procedure, the downside of balance billing. In ... healthcare provider billing a patient for the difference ... reimburse and what the provider chooses to charge. ...
Breaking Medicine News(10 mins):Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3
... youths with chest pain who are white and have ... Black children and kids without private insurance are less ... private insurance to be given tests when seen for ... has found. , Cincinnati Children,s Hospital Medical Center researchers ...
... Topics ... ... pediatric experts from Children’s National Medical Center will be presenting at the 2009 ... in Washington. , , , , ,Children’s pediatric specialists will be discussing many topics and ...
... STATION, Texas, Oct. 16 On Friday, October 16, U.S. ... more than 2,000 service leaders in Texas to celebrate the ... new call to Americans to serve in their communities. , ... which he invoked "A Thousand Points of Light" to salute ...
... ANCHORAGE, Alaska, Oct. 16 Rotary International has declared October ... stamp out polio worldwide. , In the past 10 years ... $680,000 to achieve the dream of a polio-free world. They ... to help local people with national immunization days. , In ...
... (Oct. 16, 2009) The notion that training teachers in ... academic performance now has real data behind it: Research assembled ... 16 issue of Science shows that high ... called Regents examinations, can be significantly improved if they are ...
... use are known contributors to adolescents engaging in ... such as unwanted pregnancies, sexually transmitted illnesses, drug ... fewer than half of pediatricians report screening patients ... the diagnostic test developed and currently being employed ...
Cached Medicine News:Health News:Race, Insurance May Affect Testing of Kids in ER 2Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference, 2Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 2Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 3Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 4Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 5Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 6Health News:Science study: Teacher participation in Columbia program improves student achievement in science 2Health News:Science study: Teacher participation in Columbia program improves student achievement in science 3Health News:Science study: Teacher participation in Columbia program improves student achievement in science 4Health News:Substance abuse diagnostic test for teens can also predict high risk sexual behavior 2
Space-saving storage cabinets for microscope slides....
High-quality, epoxy-coated, stackable steel cabinets for the storage of microscope slides, slide filing wallets, processing cassettes, tissue blocks, transparencies and A5 index cards....
All metal for storing 5 cm x 5 cm (2 inches x 2 inches) 35 mm color slides. Each is individually crafted of high grade steel and finished with a durable baked enamel finish....
A prepared Microscope Slide Cataloging and Storage System....
Medicine Products: